{"id":"W2049063681","doi":"10.1016/j.ejca.2010.02.032","title":"Bosutinib: A review of preclinical studies in chronic myelogenous leukaemia","year":2010,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Bosutinib; Chronic myelogenous leukemia; Imatinib; Cancer research; Medicine; Pharmacology; ABL; breakpoint cluster region; Leukemia; Dasatinib; Myeloid leukemia; Immunology; Tyrosine kinase; Internal medicine; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003061594,0.0005343824,0.005096277,0.0003058061,0.00002584154,0.000006333956,0.0005043058,0.0001538375,0.0004012083],"category_scores_gemma":[0.001441413,0.000348529,0.001325957,0.0004215421,0.0002864304,0.00006039266,0.0001587286,0.002270765,0.00006979283],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003682341,"about_ca_system_score_gemma":0.008232834,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008394511,"about_ca_topic_score_gemma":0.00002428146,"domain_scores_codex":[0.9940924,0.001009649,0.003493107,0.0003581286,0.0006608272,0.0003859076],"domain_scores_gemma":[0.9946942,0.0004062013,0.003455747,0.000663604,0.0005521515,0.0002281441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004063782,0.00008708639,0.00002990775,0.1604876,0.001140332,0.001681108,0.00008518843,5.724149e-7,0.000002716777,0.000001916256,0.004322809,0.8321201],"study_design_scores_gemma":[0.001471612,0.0005842804,0.00005535068,0.391906,0.003158129,0.001118653,0.000005004882,1.473737e-7,0.000002692851,0.000001043255,0.601557,0.0001401187],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009999608,0.9953416,0.000001057531,0.0001682906,0.001061621,0.0008826559,0.0000251823,0.00001048381,0.002409099],"genre_scores_gemma":[0.00002879021,0.9964013,0.0003184209,0.0002295819,0.001986281,0.00001915946,0.00001034643,0.0001363644,0.000869797],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.83198,"threshold_uncertainty_score":0.9998966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1775104349152478,"score_gpt":0.4782960529789655,"score_spread":0.3007856180637177,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}